Every SEC Form 3/4/5 on record for this filer (CIK 1410289) — 11 issuers, 29 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| ABSI | Absci Corp | Director | 2025-07-09 → 2026-06-15 | 4 | — |
| KURA | Kura Oncology, Inc. | Director | 2018-11-08 → 2026-06-04 | 10 | — |
| TLSI | TriSalus Life Sciences, Inc. | CEO and President · Director | 2023-08-15 → 2026-05-18 | 12 | $350,656 |
| ACAAU | Averin Capital Acquisition Corp. | Director | 2026-02-18 → 2026-02-18 | 1 | — |
| OMGA | Omega Therapeutics, Inc. | Director · lapsed | 2021-07-29 → 2024-06-21 | 4 | — |
| RXDX | Prometheus Biosciences, Inc. | Director · lapsed | 2021-03-11 → 2023-06-16 | 5 | — |
| CHRS | Coherus Oncology, Inc. | Director · lapsed | 2016-05-26 → 2021-01-13 | 7 | −$966,847 |
| ALIM | ALIMERA SCIENCES INC | Director · lapsed | 2018-06-21 → 2020-06-22 | 4 | — |
| NVLN | NOVELION THERAPEUTICS INC. | Chief Executive Officer · Director · lapsed | 2016-12-01 → 2017-05-11 | 4 | — |
| AEGR | Aegerion Pharmaceuticals, Inc. | Chief Executive Officer · Director · lapsed | 2016-01-11 → 2016-11-30 | 4 | — |
| RCPT | Receptos, Inc. | Director · lapsed | 2015-08-27 → 2015-08-27 | 1 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| TLSI | 2026-05-15 | Buy | 39,682 | $2.59 | $102,776 | 1,065,215 |
| TLSI | 2026-03-17 | Sell | 15,944 | $3.85 | $61,384 | 752,987 |
| TLSI | 2026-03-11 | Sell | 4,358 | $4.13 | $17,999 | 768,931 |
| TLSI | 2026-02-23 | Buy | 30,487 | $4.10 | $124,997 | 773,289 |
| TLSI | 2025-01-30 | Buy | 5,010 | $5.28 | $26,453 | 444,259 |
4 of 11 issuers are covered and open a security page; the rest are on file here only.
